 | Up a level |
Cabral-Miranda, Gustavo; Lim, Stephanie M.; Mohsen, Mona O.; Pobelov, Ilya V.; Roesti, Elisa S.; Heath, Matthew D.; Skinner, Murray A.; Kramer, Matthias F.; Martina, Byron E. E.; Bachmann, Martin F. (2020). Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72. Vaccines, 8(1) MDPI 10.3390/vaccines8010094
Cabral-Miranda, Gustavo; Lim, Stephanie M; Mohsen, Mona O.; Pobelov, Ilya V.; Rösti, Elisa S.; Heath, Matthew D; Skinner, Murray A; Kramer, Matthias F; Martina, Byron E E; Bachmann, Martin F. (2019). Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines, 7(3), p. 72. MDPI 10.3390/vaccines7030072
Cabral de Miranda, Gustavo; M Salman, Ahmed; Mohsen, Mona Omar Mahmoud; Storni, Federico Lorenzo; Rösti, Elisa Simona; A Skinner, Murray; D Heath, Matthew; F Kramer, Matthias; M Khan, Shahid; J Janse, Chris; V S Hill, Adrian; Bachmann, Martin (2018). DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines. Diseases, 6(4) MDPI 10.3390/diseases6040107
